# Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.

> **NCT00150449** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 511 (—)

## Conditions studied

- Anxiety Neuroses

## Interventions

- **DRUG:** Pregabalin

## Key facts

- **NCT ID:** NCT00150449
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 511 (—)
- **Last updated:** 2006-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00150449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00150449, "Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00150449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*